Genient Technologies Participated in UP-UK MICROCON 2026 at SGPGIMS, Lucknow
By Genient
Genient Technologies participated in UP-UK MICROCON 2026, the 21st Annual Conference of the UP–UK State Chapter of the Indian Association of Medical Microbiologists (IAMM), held at SGPGIMS, Lucknow, on 6–7 February 2026.
Advances in Clinical Microbiology
Organised under the theme “Advances in Clinical Microbiology: Shaping Patient Care,” the conference brought together medical microbiologists, clinicians, researchers, and laboratory professionals for scientific exchange, expert discussions, and focused pre-conference educational workshops.
The event served as an important forum for conversations around the evolving role of clinical microbiology, molecular diagnostics, genomics, antimicrobial resistance (AMR), and infectious disease management.
Genient’s Presence at Booth 14
At Booth 14, Genient Technologies engaged with delegates on its approach to clinical genomics, molecular microbiology, and decision-grade workflows designed to support stronger patient-care outcomes.
The company highlighted the importance of reproducible and audit-ready molecular workflows, standardised interpretation for actionable reporting, and diagnostic solutions aligned with real-world hospital and public health needs.
Strengthening Diagnostic Innovation
The conference and workshop sessions reinforced the growing momentum in rapid diagnostics, AMR surveillance, molecular testing, and clinically relevant interpretation. These discussions reflected the increasing need for diagnostic systems that combine scientific rigour with practical clinical value.
Genient Technologies also acknowledged the contributions of its collaborating ecosystem and participating professionals, including Bioeksen R&D Technologies, Invitek Diagnostics, and ABL Diagnostics S.A., while expressing appreciation to the organisers, faculty, and delegates for enabling meaningful scientific exchange and collaboration.
Through its participation in UP-UK MICROCON 2026, Genient Technologies reaffirmed its commitment to supporting clinical microbiology laboratories, molecular diagnostics, genomics-led workflows, and improved patient outcomes across India.